Deutsche Bank AG Purchases New Position in Acadia Healthcare Company, Inc. $ACHC

Deutsche Bank AG acquired a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the 2nd quarter, Holdings Channel reports. The fund acquired 1,684,607 shares of the company’s stock, valued at approximately $49,746,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in ACHC. EverSource Wealth Advisors LLC lifted its holdings in shares of Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after purchasing an additional 497 shares during the last quarter. Federated Hermes Inc. increased its position in Acadia Healthcare by 1.5% during the fourth quarter. Federated Hermes Inc. now owns 43,913 shares of the company’s stock worth $623,000 after buying an additional 668 shares during the period. Price T Rowe Associates Inc. MD lifted its stake in Acadia Healthcare by 0.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 74,907 shares of the company’s stock valued at $1,063,000 after buying an additional 696 shares during the last quarter. Public Employees Retirement System of Ohio boosted its holdings in shares of Acadia Healthcare by 2.8% in the third quarter. Public Employees Retirement System of Ohio now owns 31,335 shares of the company’s stock valued at $776,000 after acquiring an additional 867 shares during the period. Finally, Treasurer of the State of North Carolina boosted its holdings in shares of Acadia Healthcare by 2.1% in the second quarter. Treasurer of the State of North Carolina now owns 42,502 shares of the company’s stock valued at $964,000 after acquiring an additional 867 shares during the period.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on ACHC. UBS Group lifted their target price on shares of Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a report on Thursday, July 9th. Barclays increased their price target on shares of Acadia Healthcare from $25.00 to $32.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 30th. Jefferies Financial Group raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and raised their price objective for the stock from $24.50 to $30.00 in a research report on Wednesday, June 3rd. TD Cowen upped their target price on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Finally, Guggenheim raised their price target on Acadia Healthcare from $38.00 to $39.00 and gave the stock a “buy” rating in a report on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, Acadia Healthcare has an average rating of “Hold” and a consensus price target of $29.85.

Acadia Healthcare Stock Performance

Shares of ACHC opened at $26.97 on Friday. The stock has a market capitalization of $2.51 billion, a P/E ratio of -2.17, a P/E/G ratio of 8.86 and a beta of 0.64. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.57 and a current ratio of 1.57. Acadia Healthcare Company, Inc. has a 1 year low of $11.43 and a 1 year high of $35.83. The company’s fifty day moving average is $29.91 and its two-hundred day moving average is $25.48.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, topping the consensus estimate of $0.35 by $0.03. The company had revenue of $865.84 million during the quarter, compared to analysts’ expectations of $844.19 million. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The business’s revenue was down .4% on a year-over-year basis. During the same quarter last year, the business earned $0.83 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. On average, sell-side analysts predict that Acadia Healthcare Company, Inc. will post 1.54 earnings per share for the current year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.